The reading room / Peptide research blog

Peptide research, explained.

Detailed guides to peptide identity, biological pathways, analytical methods and clinical evidence. Search the reading room or follow a research topic.

Browse 13 research topics
Reset filters

All guides & articles

61–72 of 149 guides

Page 6 of 13
Two separate rule systems. Health-product record: Canadian product authorization; Anti-doping rules: Substance and sport context; Date: Use the applicable annual list.Research Practice

Peptides and WADA in Canada: Product Approval Is Not Anti-Doping Permission

Peptides and WADA require a separate check from Canadian medicine authorization. A product can have a medical use while still being subject to sport restrictions, and a research-use label does not provide anti-doping permission.

Updated 2026-11-06 ↗
Research label / research pathway. RUO wording: A product label; Actual activity: Classify the real use; Human clinical trial: Dedicated authorization pathway.Research Practice

“Research Use Only” Peptides in Canada: What the Label Does Not Establish

Research use only peptides do not gain Canadian authorization simply from the words on a label. Health Canada’s current research guidance explicitly says that a research-use label does not make a product legal to import or sell.

Updated 2026-11-06 ↗
Retatrutide: research to product. Receptors: GLP-1 · GIP · glucagon; Clinical trials: Defined investigational product; Canadian status: Check the exact product.Research Practice

Retatrutide in Canada: Clinical Trials, Product Status and “GLP-3”

Retatrutide in Canada should be checked through both clinical-trial records and Canadian product information. These are separate records.

Updated 2026-11-06 ↗
Oral semaglutide is a formulation. Peptide ingredient: Semaglutide identity; Finished tablet: A defined formulation; Evidence and record: Match product and route.Peptide Fundamentals

Rybelsus in Canada: How Oral Semaglutide Differs from a Research Peptide

Rybelsus in Canada is an oral semaglutide medicine, not a generic label for any peptide taken by mouth. Its Health Canada product record identifies a prescription tablet with oral administration.

Updated 2026-11-06 ↗
STEP 8: a direct comparison. Semaglutide arm: A specified trial intervention; Liraglutide arm: A specified trial intervention; Shared context: 68 weeks · adults without diabetes.Research Practice

Semaglutide vs Liraglutide: What the STEP 8 Head-to-Head Trial Shows

Semaglutide vs liraglutide has direct randomized evidence from STEP 8. That is more informative for its particular question than comparing unrelated trials.

Updated 2026-11-06 ↗
A branching catalogue filter separates peptides from other materials and single compounds from blends before selecting a report.Research Practice

Swiss Chems vs BioTech Peptides: Product Forms and Testing Records

A form- and method-focused comparison that separates product categories, public reports and complaint policies from claims of demonstrated quality.

Updated 2026-11-06 ↗
The Peptide Labs and Peptide Warehouse dispatch envelopes connected to separate lot-document folders.Research Practice

The Peptide Labs vs Peptide Warehouse: Canadian Supplier Records Compared

A Canadian-facing comparison of documentation access, dispatch information and product records, with seller claims kept separate from independent verification.

Updated 2026-11-09T09:06:28.317Z ↗
Testing: lab, method and sample. Laboratory: Competence and scope; Procedure: Fit for the intended question; Sample: Identity and custody.Analytical Methods

Third-Party Peptide Testing: ISO 17025, Scope and What “Independent” Means

Third-party peptide testing is useful only when the laboratory, sample and method match the question being asked. Independence from a seller is one consideration.

Updated 2026-11-06 ↗
US and Canada comparison ledgers show separate destination, dispatch, currency and lot-document fields.Research Practice

US vs Canada Peptide Providers: Destination, Documents and Cost Compared

A destination-first comparison that separates a supplier’s shipping policy, manufacturing claims, documentation and quoted cost.

Updated 2026-11-09T09:06:28.317Z ↗
Authenticate the chain of records. Report: Original laboratory source; Sample: Identity and custody; Lot: Match the material record.Documentation & Traceability

How to Verify a Peptide COA: Document Authenticity and the Sample-Custody Gap

To verify a peptide COA, separate document authenticity from sample identity. An authentic laboratory report can still concern a sample that has not been independently connected to the material in a particular container.

Updated 2026-11-06 ↗
three-dimensional trabecular-bone teaching specimen placed between two different evidence binders Abaloparatide and Teriparatide, in the Abaloparatide vs Teriparatide research file.Peptide Fundamentals

Abaloparatide vs Teriparatide: Bone Peptide Evidence

Abaloparatide and teriparatide are related to PTH-family biology and have product-specific osteoporosis evidence.

Updated 2026-10-29 ↗
Two physically thick identity dossiers Afamelanotide and Melanotan II, with distinct product-record and early-study evidence sleeves, in the Afamelanotide vs Melanotan II research file.Peptide Fundamentals

Afamelanotide vs Melanotan II: Why the Difference Matters

Afamelanotide’s regulated implant record concerns pain-free light exposure in adults with erythropoietic protoporphyria.

Updated 2026-10-29 ↗
Peptide Research Guides & Evidence: Page 6 | PeptideTwo